6W8H

H-PGDS complexed with inhibitor 1Y

6W8H の概要

• エントリーDOI: 10.2210/pdb6w8h/pdb
• 分子名称: Hematopoietic prostaglandin D synthase, GLUTATHIONE, 1,2-ETHANEDIOL, ... (5 entities in total)
• 機能のキーワード: glutathione s-transferase, hydrolase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 51749.26

構造登録者

Shewchuk, L.M.,Ward, P. (登録日: 2020-03-20, 公開日: 2020-11-04, 最終更新日: 2023-10-18)

• 主引用文献: Cadilla, R.,Deaton, D.N.,Do, Y.,Elkins, P.A.,Ennulat, D.,Guss, J.H.,Holt, J.,Jeune, M.R.,King, A.G.,Klapwijk, J.C.,Kramer, H.F.,Kramer, N.J.,Laffan, S.B.,Masuria, P.I.,McDougal, A.V.,Mortenson, P.N.,Musetti, C.,Peckham, G.E.,Pietrak, B.L.,Poole, C.,Price, D.J.,Rendina, A.R.,Sati, G.,Saxty, G.,Shearer, B.G.,Shewchuk, L.M.,Sneddon, H.F.,Stewart, E.L.,Stuart, J.D.,Thomas, D.N.,Thomson, S.A.,Ward, P.,Wilson, J.W.,Xu, T.,Youngman, M.A.; The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure.; Bioorg.Med.Chem., 28:115791-115791, 2020; PubMed: 33059303; DOI: 10.1016/j.bmc.2020.115791

実験手法

X-RAY DIFFRACTION (1.97 Å)